Frontiers in oncology.

The Cancer Imaging and Image-directed Interventions Section is dedicated to the publication of results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment. The section will accept studies from the entire field of cancer imaging: results from the routine use of clinical imaging in both radiology and ...Our Cancer Center managed to continue oncology services throughout the COVID pandemic, whereas other Centers may have redeployed staff that precluded this. It is also a strength of our study that we used clearly defined definitions of COVID-19 severity, as well as a DAG to develop the different models, as to date very limited knowledge is …PCNSTCL with isolated brain involvement occurred in two of 1,040 patients (0.19%). Out of 11 patients with CNS and systemic disease at presentation, brain involvement was documented in four patients, isolated leptomeningeal disease was diagnosed in four patients, combined parenchymal and leptomeningeal disease was detected in two …The Cancer Genetics specialty section will facilitate the publication of high-quality original research and review articles pertaining to the genetic, genomic and molecular aspects of cancer, and technical advances that facilitate progress in this field. Focused primarily on molecular genetic aberrations driving malignant processes in human ...

Cleveland Clinic Abu Dhabi organizes Frontiers In Advanced Hepato-Biliary Cancers And Transplant Oncology 2024, About.Nov 15, 2022 ... "Structure Matters: A Call to Action," presented by Robert A. Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center.Integrative oncology becomes a critical component of evidence-informed, patient-centered cancer care, helping patients and their families navigate the ...

Resurchify provides impact factor, h-index, SJR, ranking, publisher, ISSN, and other details of Frontiers in Oncology, a cancer research journal. See …Frontiers in Oncology. doi 10.3389/fonc.2024.1370059. 249 views Original Research. Published on 26 Apr 2024 Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis. in Radiation Oncology. Simon K. B. Spohn;

Integrative oncology becomes a critical component of evidence-informed, patient-centered cancer care, helping patients and their families navigate the ...Chengli Wang. Liling Lin. Jiayao Wu. Ganglan Fu. Zhongqi Liu. Minghui Cao. Frontiers in Oncology. doi 10.3389/fonc.2024.1345766. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of …Frontiers in Oncology ... Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With ...

Focus fcu

Pediatric Oncology. sergi aranda. National Center for Genomic Analysis, Center for Genomic Regulation (CRG) Barcelona, Spain. Associate Editor. Pediatric Oncology. nicoleta arva. Feinberg School of Medicine, Northwestern University. …

Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage ib non-small-cell lung cancer: calgb 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups.List of posts by tag Frontiers in Oncology Scope. Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies. The special issue will focus on the application of new methods, viewpoints and technologies for the diagnosis and treatment of brain tumors including brain ...Jul 6, 2018 · The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 296 articles published in 2015 and 2016, and for CiteScore is based on 4,138 citations in 2017 to 930 articles published in 2014, 2015 and 2016. A total of 222 journals are listed in the Oncology category in the 2017 JCR edition, of which 37 are Open Access. Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ...

Aug 18, 2020 · Chronic Stress Promotes Cancer Development. Stress is an inevitable part of life. Chronic stress on account of reasons like adversity, depression, anxiety, or loneliness/social isolation can endanger human health. Recent studies have shown that chronic stress can induce tumorigenesis and promote cancer development. 1 Introduction. RMS is the most common soft tissue sarcoma in children, accounting for about half of all soft tissue tumors, which are usually localized in the extremities, trunk, head, and neck (1, 2).It is rarely observed in adults and only accounts for 3% of adult soft tissue sarcomas, which has a significantly worse prognosis compared to …Added 14 August 2012 • Updated 12 January 2024. A peer-reviewed, open access journal in cancer research, clinical oncology, cancer genetics, molecular targets & surgical …Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ).The association between objective imaging response and first line immune checkpoint inhibitor (ICI) therapy regimes in advanced melanoma remains …

Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ... Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ...

May 9, 2024 · Biological Functions and Therapeutic Potential of SRY related high mobility group box 5 (SOX5) in human cancer. Xue juan Di. Wanfang Xiang. Ming-qin Cai. Xiaoyun Lv. Frontiers in Oncology. doi 10.3389/fonc.2024.1332148. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression. 4 days ago · timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology. priya ranjit bhosale. University of Texas MD Anderson Cancer Center. Houston, United States. Associate Editor. Gynecological Oncology.6,872 views. 5 articles. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Jan 9, 2024 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...4 days ago · Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors. 4 days ago · Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors. Frontiers in Immuno-Oncology. Print Special Issue Flyer. Special Issue Editors. Special Issue Information. Keywords. Published Papers. A special issue of …

Boom boom

Frontiers in Oncology 影响因子：4.848 Frontiers in Oral Health. P. Frontiers in Pediatrics 影响因子：2.634 Frontiers in Pharmacology 影响因子：4.225

Frontiers in Oncology 影响因子：4.848 Frontiers in Oral Health. P. Frontiers in Pediatrics 影响因子：2.634 Frontiers in Pharmacology 影响因子：4.225Introduction. Non-communicable Diseases (NCD) were responsible for 15 million premature deaths (30-69 years) worldwide in 2016, with more than 85% of these deaths occurring in low- and middle …Frontiers in Oncology publishes peer-reviewed articles across the entire field of cancer research, from basic to clinical. It is a multidisciplinary journal with a high impact factor and a global reach, ranking among the top journals in the category of oncology.32. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz JF, Paillaud E, et al. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer (2023) 23(1):17. doi: …Pediatric Oncology. sergi aranda. National Center for Genomic Analysis, Center for Genomic Regulation (CRG) Barcelona, Spain. Associate Editor. Pediatric Oncology. nicoleta arva. Feinberg School of Medicine, Northwestern University. …See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Oncology. Oncology is a specialized field of medicine that focuses on the prevention, diagnosis, and treatment of various types of cancer. Our Research Topics explore key advancements in oncology which have led to significant breakthroughs in cancer care, such as targeted therapies, immunotherapy, and precision medicine.Baohua Hou. Frontiers in Oncology. doi 10.3389/fonc.2024.1332387. 161 views. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of …

Frontier Airlines is a popular low-cost carrier that offers budget-friendly travel options for those looking to explore new destinations without breaking the bank. With a focus on ... Frontiers' open access policy ensures high visibility and maximum exposure of your work - anyone can read your Frontiers articles, without paying any access or subscription costs. Your work can be shared under the terms of the Creative Commons Attribution License. Frontiers submits all its journals for archiving in PubMed Central and PubMed ... Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer. Frontiers Instagram:https://instagram. postcard inn islamorada 4 days ago · Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors. Special Issue Information. Dear Colleagues,. Pancreatic adenocarcinoma is an aggressive malignancy associated with poor prognosis and is the fourth most common ... flight to saudi arabia Scope. Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies. chicago to ahmedabad flight PCNSTCL with isolated brain involvement occurred in two of 1,040 patients (0.19%). Out of 11 patients with CNS and systemic disease at presentation, brain involvement was documented in four patients, isolated leptomeningeal disease was diagnosed in four patients, combined parenchymal and leptomeningeal disease was detected in two …3 days ago · James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. tj max payment James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. geo maps Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and … check my subway gift card balance The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ... coverstar app In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ...penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies. red and blue lights Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). a stolen life book Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ... flights cincinnati priya ranjit bhosale. University of Texas MD Anderson Cancer Center. Houston, United States. Associate Editor. Gynecological Oncology.Frontiers in Oncology. doi 10.3389/fonc.2024.1334846. 2,162 views Perspective. Published on 18 Mar 2024 Prevention of cisplatin-induced hearing loss in children: achievements and challenges for evidence-based implementation of sodium Thiosulfate. in Pediatric Oncology. the conjuring watch SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associate Editor. Cancer Molecular Targets and Therapeutics. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics. Frontiers